| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ab Osterhaus | Q354237 |
| Roel Coutinho | Q2246926 | ||
| Stephan Günther | Q2343304 | ||
| Ann Vossen | Q30514108 | ||
| Marion Koopmans | Q46090938 | ||
| Aura Timen | Q87727137 | ||
| Petra Emmerich | Q101437870 | ||
| Gerard J J van Doornum | Q117792034 | ||
| P2093 | author name string | Sabine Dittrich | |
| Jaap T van Dissel | |||
| Franchette van den Berkmortel | |||
| Kees M Verduin | |||
| P2860 | cites work | Marburg virus infection detected in a common African bat | Q21090111 |
| Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. | Q27471311 | ||
| Viral haemorrhagic fevers in Europe--effective control requires a co-ordinated response | Q28182505 | ||
| Filoviral haemorrhagic fevers | Q33634448 | ||
| Studies of reservoir hosts for Marburg virus | Q33877879 | ||
| Marburg and Ebola viruses as aerosol threats | Q33983654 | ||
| Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions | Q34010415 | ||
| Epidemiologic Investigation of Marburg Virus Disease, Southern Africa, 1975 * | Q34054088 | ||
| Marburg-virus disease in Kenya | Q34054741 | ||
| Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya | Q34063229 | ||
| Hemorrhagic fever viruses as biological weapons: medical and public health management | Q34126496 | ||
| Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo | Q34289541 | ||
| Management of patients in Germany with suspected viral haemorrhagic fever and other potentially lethal contagious infections | Q35083821 | ||
| Serosurvey on household contacts of Marburg hemorrhagic fever patients | Q35793913 | ||
| Short communication: a cluster of Marburg virus disease involving an infant | Q38914892 | ||
| Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005. | Q40511834 | ||
| Imported Lassa fever in Germany: surveillance and management of contact persons | Q40559139 | ||
| Outbreake of Marburg virus disease in Johannesburg. | Q55065905 | ||
| Outbreak of Marburg haemorrhagic fever: Uganda, June-August 2007 | Q56918608 | ||
| Marburg fever, Democratic Republic of the Congo | Q64360789 | ||
| Viral haemorrhagic fever/Marburg, Democratic Republic of the Congo | Q64360793 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1171-1175 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | Response to imported case of Marburg hemorrhagic fever, the Netherland | |
| P478 | volume | 15 |
| Q35798489 | A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'. |
| Q36973175 | A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles |
| Q37504760 | A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever |
| Q62240884 | A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation |
| Q40297083 | A strategy to simultaneously eradicate the natural reservoirs of rabies and Ebola virus |
| Q34186562 | Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever |
| Q50034302 | Antibody Responses to Marburg Virus in Egyptian Rousette Bats and Their Role in Protection against Infection. |
| Q33538454 | Antiviral activity of a small-molecule inhibitor of filovirus infection |
| Q91912881 | Application of a quantitative entry assessment model to compare the relative risk of incursion of zoonotic bat-borne viruses into European Union Member States |
| Q38871691 | Bats and other reservoir hosts of Filoviridae. Danger of epidemic on the African continent?--a deductive literature analysis |
| Q38069691 | Bats and their virome: an important source of emerging viruses capable of infecting humans. |
| Q34995659 | Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease |
| Q35446144 | Clinical aspects of Marburg hemorrhagic fever |
| Q64080537 | Comparative analysis of serologic cross-reactivity using convalescent sera from filovirus-experimentally infected fruit bats |
| Q33956387 | Current perspectives on the phylogeny of Filoviridae |
| Q36085810 | Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene |
| Q54261116 | Development and characterization of a guinea pig model for Marburg virus. |
| Q30224036 | Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys. |
| Q36238036 | Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network |
| Q36155931 | Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells |
| Q21558510 | Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? |
| Q38268877 | Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing |
| Q34059380 | Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes |
| Q34664182 | Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation |
| Q42364377 | Ecological Niche Modeling for Filoviruses: A Risk Map for Ebola and Marburg Virus Disease Outbreaks in Uganda. |
| Q38677951 | Ecology of Filoviruses |
| Q27314945 | Electron tomography reveals the steps in filovirus budding |
| Q37402507 | Emergence of Ebola virus disease in a french acute care setting: a simulation study based on documented inter-individual contacts |
| Q37670961 | Emerging and re-emerging infections at the turn of the millennium |
| Q33588444 | Emerging filoviral disease in Uganda: proposed explanations and research directions |
| Q33680083 | Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection |
| Q89972099 | Experimental infection of Egyptian rousette bats (Rousettus aegyptiacus) with Sosuga virus demonstrates potential transmission routes for a bat-borne human pathogenic paramyxovirus |
| Q93145910 | Filovirus Disease Outbreaks: A Chronological Overview |
| Q35048254 | Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine |
| Q38599899 | Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus |
| Q40053025 | Filoviruses and bats |
| Q28657754 | Filoviruses in bats: current knowledge and future directions |
| Q36395831 | Forty-five years of Marburg virus research |
| Q34484140 | Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation |
| Q34843676 | Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. |
| Q55241490 | Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies. |
| Q30151580 | How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence |
| Q29364915 | Infections associated with adventure travel: A systematic review |
| Q22305521 | Intracellular events and cell fate in filovirus infection |
| Q33724625 | Isolated Case of Marburg Virus Disease, Kampala, Uganda, 2014. |
| Q92932380 | Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa |
| Q40039621 | Knowledge and attitude towards Ebola and Marburg virus diseases in Uganda using quantitative and participatory epidemiology techniques |
| Q34515519 | Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection |
| Q37513524 | Low-incidence, high-consequence pathogens |
| Q30204337 | Mapping the zoonotic niche of Marburg virus disease in Africa |
| Q54206968 | Marburg Virus Infection in Egyptian Rousette Bats, South Africa, 2013-20141. |
| Q64082058 | Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings |
| Q35852525 | Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. |
| Q92332098 | Marburg virus pathogenesis - differences and similarities in humans and animal models |
| Q38675825 | Marburg- and Ebolaviruses: A Look Back and Lessons for the Future |
| Q42939796 | Marburgvirus resurgence in Kitaka Mine bat population after extermination attempts, Uganda |
| Q37651878 | Modelling filovirus maintenance in nature by experimental transmission of Marburg virus between Egyptian rousette bats |
| Q38858365 | Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. |
| Q36654325 | No evidence for the involvement of the argasid tick Ornithodoros faini in the enzootic maintenance of marburgvirus within Egyptian rousette bats Rousettus aegyptiacus |
| Q37255209 | Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). |
| Q34028916 | Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. |
| Q91901633 | Outbreakmanagement in Nederland |
| Q30391636 | Potential for introduction of bat-borne zoonotic viruses into the EU: a review |
| Q35877436 | Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories |
| Q35675647 | Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs |
| Q97550484 | Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands |
| Q39548718 | Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays |
| Q36037694 | Retrospective evaluation of control measures for contacts of patient with Marburg hemorrhagic fever |
| Q35654347 | Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo |
| Q34440625 | Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection |
| Q41146354 | Structural requirements for the management of patients with highly contagious life-threatening infectious diseases: update 2015 |
| Q30223090 | Surveillance strategy for early detection of unusual infectious disease events |
| Q56911868 | Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda |
| Q38192567 | Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick |
| Q41822299 | The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection |
| Q38050084 | The importance of understanding the human-animal interface : from early hominins to global citizens |
| Q33918317 | The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola |
| Q36080864 | Transcriptional Profiling of the Immune Response to Marburg Virus Infection |
| Q34515978 | Transmission potential and design of adequate control measures for Marburg hemorrhagic fever |
| Q40154834 | Transport and Management of Patients With Confirmed or Suspected Ebola Virus Disease |
| Q30210429 | Transportation capacity for patients with highly infectious diseases in Europe: A survey in 16 nations |
| Q21134043 | Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus |
| Q59350254 | Virulence of Marburg Virus Angola Compared to Mt. Elgon (Musoke) in Macaques: A Pooled Survival Analysis |
Search more.